EQRX
NEWS
EQRX was acquired by Revolution Medicines in November 2023.
EQRX is pushing forward with its goal of developing more affordable novel medications that can sustain healthcare systems.
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life science startups in North America that recently launched.
JOBS
IN THE PRESS